|
1
|
Beasley R, Crane J, Lai CK and Pearce N:
Prevalence and etiology of asthma. J Allergy Clin Immunol.
105:S466–S472. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pakhale S, Mulpuru S and Boyd M: Optimal
management of severe/refractory asthma. Clin Med Insights Circ
Respir Pulm Med. 5:37–47. 2011.PubMed/NCBI
|
|
3
|
Myers TR and Tomasio L: Asthma: 2015 and
beyond. Respir Care. 56:1389–1407. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perez JF and Sanderson MJ: The frequency
of calcium oscillations induced by 5-HT, ACH, and KCl determine the
contraction of smooth muscle cells of intrapulmonary bronchioles. J
Gen Physiol. 125:535–553. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
García-Marcos L, Schuster A and Cobos
Barroso N: Inhaled corticosteroids plus long-acting β2-agonists as
a combined therapy in asthma. Expert Opin Pharmacother. 4:23–39.
2003. View Article : Google Scholar
|
|
6
|
Wijesinghe M, Perrin K, Harwood M,
Weatherall M and Beasley R: The risk of asthma mortality with
inhaled long acting β-agonists. Postgrad Med J. 84:467–472. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vathenen AS, Knox AJ, Higgins BG, Britton
JR and Tattersfield AE: Rebound increase in bronchial
responsiveness after treatment with inhaled terbutaline. Lancet.
1:554–558. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mann M, Chowdhury B, Sullivan E, Nicklas
R, Anthracite R and Meyer RJ: Serious asthma exacerbations in
asthmatics treated with high-dose formoterol. Chest. 124:70–74.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haney S and Hancox RJ: Rapid onset of
tolerance to β-agonist bronchodilation. Respir Med. 99:566–571.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones SL, Cowan JO, Flannery EM, Hancox
RJ, Herbison GP and Taylor DR: Reversing acute bronchoconstriction
in asthma: the effect of bronchodilator tolerance after treatment
with formoterol. Eur Respir J. 17:368–373. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wraight JM, Hancox RJ, Herbison GP, Cowan
JO, Flannery EM and Taylor DR: Bronchodilator tolerance: the impact
of increasing bronchoconstriction. Eur Respir J. 21:810–815. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giembycz MA and Newton R: Beyond the dogma
novel β2-adrenoceptor signalling in the airways. Eur Respir J.
27:1286–1306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goncharova EA, Goncharov DA, Zhao H, Penn
RB, Krymskaya VP and Panettieri RA Jr: β2-adrenergic receptor
agonists modulate human airway smooth muscle cell migration via
vasodilator-stimulated phosphoprotein. Am J Respir Cell Mol Biol.
46:48–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McGraw DW, Almoosa KF, Paul RJ, Kobilka BK
and Liggett SB: Antithetic regulation by β-adrenergic receptors of
Gq receptor signaling via phospholipase C underlies the airway
β-agonist paradox. J Clin Invest. 112:619–626. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chilvers ER, Lynch BJ and Challiss RA:
Dissociation between β-adrenoceptor-mediated cyclic AMP
accumulation and inhibition of histamine-stimulated
phosphoinositide metabolism in airways smooth muscle. Biochem
Pharmacol. 53:1565–1568. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitchell RW, Halayko AJ, Kahraman S,
Solway J and Wylam ME: Selective restoration of calcium coupling to
muscarinic M(3) receptors in contractile cultured airway myocytes.
Am J Physiol Lung Cell Mol Physiol. 278:L1091–L1100.
2000.PubMed/NCBI
|
|
17
|
Tronde A, Gillen M, Borgstrom L, Lotvall J
and Ankerst J: Pharmacokinetics of budesonide and formoterol
administered via 1 pressurized metered-dose inhaler in patients
with asthma and COPD. J Clin Pharmacol. 48:1300–1308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katsunuma T, Roffel AF, Elzinga CR,
Zaagsma J, Barnes PJ and Mak JC: β(2)-adrenoceptor agonist-induced
upregulation of tachykinin NK(2) receptor expression and function
in airway smooth muscle. Am J Respir Cell Mol Biol. 21:409–417.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mak JC, Roffel AF, Katsunuma T, Elzinga
CR, Zaagsma J and Barnes PJ: Up-regulation of airway smooth muscle
histamine H(1) receptor mRNA, protein, and function by
β(2)-adrenoceptor activation. Mol Pharmacol. 57:857–864.
2000.PubMed/NCBI
|
|
20
|
Song KS, Lee TJ, Kim K, Chung KC and Yoon
JH: cAMP-responding element-binding protein and c-Ets1 interact in
the regulation of ATP-dependent MUC5AC gene expression. J Biol
Chem. 283:26869–26878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lincoln TM, Dey N and Sellak H: Invited
review: cGMP-dependent protein kinase signaling mechanisms in
smooth muscle: from the regulation of tone to gene expression. J
Appl Physiol (1985). 91:1421–1430. 2001.
|
|
22
|
de Rooij J, Zwartkruis FJ, Verheijen MH,
et al: Epac is a Rap1 guanine-nucleotide-exchange factor directly
activated by cyclic AMP. Nature. 396:474–477. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sayers I, Swan C and Hall IP: The effect
of β2-adrenoceptor agonists on phospholipase C (β1) signalling in
human airway smooth muscle cells. Eur J Pharmacol. 531:9–12. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chong LK, Chowdry J, Ghahramani P and
Peachell PT: Influence of genetic polymorphisms in the
β2-adrenoceptor on desensitization in human lung mast cells.
Pharmacogenetics. 10:153–162. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kotlikoff MI and Kamm KE: Molecular
mechanisms of β-adrenergic relaxation of airway smooth muscle. Annu
Rev Physiol. 58:115–141. 1996. View Article : Google Scholar
|
|
26
|
Kume H, Hall IP, Washabau RJ, Takagi K and
Kotlikoff MI: β-adrenergic agonists regulate KCa channels in airway
smooth muscle by cAMP-dependent and -independent mechanisms. J Clin
Invest. 93:371–379. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adcock IM, Maneechotesuwan K and Usmani O:
Molecular interactions between glucocorticoids and long-acting
β2-agonists. J Allergy Clin Immunol. 110:S261–S268. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lasserson TJ, Ferrara G and Casali L:
Combination fluticasone and salmeterol versus fixed dose
combination budesonide and formoterol for chronic asthma in adults
and children. Cochrane Database Syst Rev. 7:CD0041062011.
|
